Skip to main content

Cerebral Palsy (CP)

0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
2 programs
ExoskeletonN/A1 trial
Pediatric Lower Limb ExoskeletonN/A1 trial
Active Trials
NCT07539389Recruiting30Est. Dec 2026
NCT07146932Not Yet Recruiting20Est. Jan 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Activities-based locomotor trainingN/A1 trial
Active Trials
NCT07184411Recruiting19Est. Aug 2028
ADEL
ADELKorea - Seoul
1 program
transphyseal screwN/A1 trial
Active Trials
NCT06983353Not Yet Recruiting50Est. May 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Cosmo PharmaceuticalsExoskeleton
Human BioSciencesActivities-based locomotor training
Cosmo PharmaceuticalsPediatric Lower Limb Exoskeleton
ADELtransphyseal screw

Clinical Trials (4)

Total enrollment: 119 patients across 4 trials

NCT07539389Cosmo PharmaceuticalsExoskeleton

Safety and Effectiveness of Bambini Kids Robot-Assisted Gait Training (RAGT) in Children With Cerebral Palsy

Start: Apr 2026Est. completion: Dec 202630 patients
N/ARecruiting
NCT07184411Human BioSciencesActivities-based locomotor training

Activities-based Locomotor Training in Children With Cerebral Palsy

Start: Jan 2026Est. completion: Aug 202819 patients
N/ARecruiting
NCT07146932Cosmo PharmaceuticalsPediatric Lower Limb Exoskeleton

Evaluating the Bambini Teens Exoskeleton for Pediatric Cerebral Palsy

Start: Oct 2025Est. completion: Jan 202620 patients
N/ANot Yet Recruiting
NCT06983353ADELtransphyseal screw

Guided Growth Technique Use In Treatment Of Hip Sublaxation In CP Childern

Start: Oct 2025Est. completion: May 202750 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 119 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.